High Rate of Actionable Variants Identifed by Multigene Testing for Pancreas Cancer Patients in a High Risk Clinic

被引：0
|
作者：
Wideroff, Gina [1 ]
Sussman, Daniel A. [1 ]
Hosein, Peter J. [2 ]
Silva-Smith, Rachel [2 ]
Donenberg, Talia [1 ]
机构：
[1] Univ Miami, Leonard M Miller Sch Med, Miami, FL USA
[2] Univ Miami, Miami, FL USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2018年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
24
引用
收藏
页码：S14 / S15
页数：2
相关论文
共 50 条
  • [31] A multigene signature for immunotherapy in patients with high risk non-muscle-invasive bladder cancer
    Baek, Seung-Woo
    Kim, Seon-Kyu
    Leem, Sun-Hee
    Chu, In-Sun
    CANCER RESEARCH, 2024, 84 (07)
  • [32] Multigene testing panels reveal pathogenic variants in sporadic breast cancer patients in northern China
    Liu, Yinfeng
    Zheng, Jie
    Xu, Yue
    Lv, Ji
    Wu, Zizheng
    Feng, Kai
    Liu, Jiani
    Yan, Weitao
    Wei, Liguang
    Zhao, Jiangman
    Jiang, Lisha
    Han, Meng
    FRONTIERS IN GENETICS, 2023, 14
  • [33] A Multigene panel testing reveals high prevalence of germline mutations at prostate cancer
    Arranz Ledo, Monica
    Lastra Aras, Enrique
    Abella Santos, Luis E.
    Ferreira Alonso, Raquel
    Hernandez Sanz, Lara
    Martinez Martin, Noemy
    Infante, Mar
    Duran, Mercedes
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2023, 31 : 248 - 248
  • [34] A targeted panel of actionable high-risk hereditary cancer predisposition genes to identify patients with pathogenic/likely pathogenic variants (PVs) irrespective of meeting established NCCN testing criteria.
    Lee, Sarah S.
    Zhang, Jingwen
    Mackall, Mia
    Bristow, Sara L.
    Malhotra, Meenakshi
    ElNaggar, Adam
    Souter, Vivienne
    Liu, Minetta C.
    Pothuri, Bhavana
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [35] Prevalence of pathogenic germline cancer risk variants in testicular cancer patients: Identifying high risk groups
    Ramamurthy, Chethan
    Nassar, Amin H.
    Abou Alaiwi, Sarah
    Adib, Elio
    Akl, Elie W.
    Yang, Shan
    Esplin, Edward D.
    Liss, Michael A.
    Tomlinson, Gail E.
    Sonpavde, Guru P.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (03) : 113.e9 - 113.e15
  • [36] Multigene panels in Ashkenazi Jewish patients yield high rates of actionable mutations in multiple non-BRCA cancer-associated genes
    Frey, Melissa K.
    Sandler, Gabriella
    Sobolev, Rachel
    Kim, Sarah H.
    Chambers, Rachelle
    Bassett, Rebecca Y.
    Martineau, Jessica
    Sapra, Katherine J.
    Boyd, Leslie
    Curtin, John P.
    Pothuri, Bhavana
    Blank, Stephanie V.
    GYNECOLOGIC ONCOLOGY, 2017, 146 (01) : 123 - 128
  • [37] The no-show rate in a high-risk obstetric clinic
    Campbell, JD
    Chez, RA
    Queen, T
    Barcelo, A
    Patron, E
    JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE, 2000, 9 (08): : 891 - 895
  • [38] Rate of Genetic Testing and High-Risk Screening in Patients Diagnosed with Breast Cancer under Age 40
    Velazquez, Christine
    Madeka, Isheeta
    Hsu, Fang-Chi
    Howard-McNatt, Marissa
    Levine, Edward A.
    Chiba, Akiko
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2020, 231 (04) : S41 - S41
  • [39] Cardiopulmonary exercise testing in the evaluation of high risk patients with lung cancer
    MAO YoushengHE JieYAN ShaopingDong JingsiCHENG GuiyuSUN KelinLIU Xiangyang FANG DekangLI JianWANG Yonggang and HUANG Jinfeng Department of Thoracic Surgical OncologyCancer Hospital Chinese Academy of Medical SciencesPeking Union Medical CollegeBeijing China
    中华医学杂志（英文版）, 2010, (21) : 3089 - 3094
  • [40] Benefits and safety of multigene panel testing in patients at risk for hereditary breast cancer.
    Kapoor, Nimmi S.
    Curcio, Lisa D.
    Blakemore, Carlee A.
    Bremner, Amy K.
    McFarland, Rachel E.
    West, John G.
    Banks, Kimberly C.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (28)
12345